Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | PLA2G7 | Q13093 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 5/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | GALR3 | O60755 | 1/20 | 0.46 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.46 |
| ▸ | MIF | P14174 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | UNG | P13051 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8613027 | 0.85 | ATM (0.59) | ATMPLA2G7MEN1KMT2ALMNA | |
| SCHEMBL8291064 | 0.85 | ATM (0.59) | ATMPLA2G7MEN1KMT2ALMNA | |
| SCHEMBL14077931 | 0.83 | PLA2G7 (0.53) | ATMPLA2G7MEN1KMT2ALMNA | |
| SCHEMBL20104790 | 0.82 | ATM (0.56) | ATMPLA2G7MEN1KMT2ALMNA | |
| SCHEMBL18196787 | 0.79 | SMN1; SMN2 (0.47) | ATMPLA2G7MEN1KMT2ALMNA | |
| SCHEMBL23992348 | 0.78 | SMN1; SMN2 (0.69) | ATMPLA2G7MEN1KMT2ALMNA | |
| SCHEMBL19303424 | 0.78 | ATM (0.52) | ATMPLA2G7MEN1KMT2ALMNA | |
| SCHEMBL10332554 | 0.77 | PLA2G7 (0.67) | PLA2G7MEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL6420965 | 0.75 | PLA2G7 (0.69) | PLA2G7MEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL11143720 | 0.75 | MAPT (0.55) | MEN1KMT2ALMNASMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10300156-B2 | Radiotracer compositions and methods | GE HEALTHCARE LIMITED (GB) | 2019-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10300156-B2 | Radiotracer compositions and methods | MET, METTL14, MEN1 | ATM 2648/4885PLA2G7 4345/4885MEN1 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.